OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging frontiers in virtual drug discovery: From quantum mechanical methods to deep learning approaches
Christoph Gorgulla, Abhilash Jayaraj, Konstantin Fackeldey, et al.
Current Opinion in Chemical Biology (2022) Vol. 69, pp. 102156-102156
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Past, Present, and Future Perspectives on Computer-Aided Drug Design Methodologies
Davide Bassani, Stefano Moro
Molecules (2023) Vol. 28, Iss. 9, pp. 3906-3906
Open Access | Times Cited: 53

Integrating artificial intelligence into the modernization of traditional Chinese medicine industry: a review
Enyu Zhou, Qin Shen, Yang Hou
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 16

Artificial intelligence revolutionizing drug development: Exploring opportunities and challenges
Prafulla Tiwari, Rishi Pal, Manju J. Chaudhary, et al.
Drug Development Research (2023) Vol. 84, Iss. 8, pp. 1652-1663
Closed Access | Times Cited: 37

Artificial intelligence enabled ChatGPT and large language models in drug target discovery, drug discovery, and development
Chiranjib Chakraborty, Manojit Bhattacharya, Sang‐Soo Lee
Molecular Therapy — Nucleic Acids (2023) Vol. 33, pp. 866-868
Open Access | Times Cited: 36

Quantum mechanical-based strategies in drug discovery: Finding the pace to new challenges in drug design
Tiziana Ginex, Javier Vázquez, Carolina Estarellas, et al.
Current Opinion in Structural Biology (2024) Vol. 87, pp. 102870-102870
Open Access | Times Cited: 11

Recent Advances in Quantum Computing for Drug Discovery and Development
Gautam Kumar, Sahil Yadav, Aniruddha Mukherjee, et al.
IEEE Access (2024) Vol. 12, pp. 64491-64509
Open Access | Times Cited: 8

Protein aggregation and therapeutic strategies in SOD1- and TDP-43- linked ALS
Maria Tsekrekou, Maria Giannakou, Katerina Papanikolopoulou, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 8

History, development, and principles of large language models: an introductory survey
Zichong Wang, Zhibo Chu, Thang Viet Doan, et al.
AI and Ethics (2024)
Closed Access | Times Cited: 6

Geometrical and thermodynamic stability of govaniadine scaffold adducts with dopamine receptor D1
Ram Lal Shrestha, Binita Maharjan, Timila Shrestha, et al.
Results in Chemistry (2024) Vol. 7, pp. 101363-101363
Open Access | Times Cited: 5

The impact of library size and scale of testing on virtual screening
Fangyu Liu, Olivier Mailhot, Isabella Glenn, et al.
Nature Chemical Biology (2025)
Open Access

Machine Learning Advances in Predicting Peptide/Protein‐Protein Interactions Based on Sequence Information for Lead Peptides Discovery
Jiahao Ye, Li An, Hao Zheng, et al.
Advanced Biology (2023) Vol. 7, Iss. 6
Closed Access | Times Cited: 12

Revolutionizing drug discovery: an AI-powered transformation of molecular docking
Adeola Abraham Fadahunsi, Henrietta Onyinye Uzoeto, Nkwachukwu Oziamara Okoro, et al.
Medicinal Chemistry Research (2024)
Closed Access | Times Cited: 4

The impact of Library Size and Scale of Testing on Virtual Screening
Fangyu Liu, Olivier Mailhot, Isabella Glenn, et al.
(2024)
Open Access | Times Cited: 2

Berbamine inhibits porcine epidemic diarrhea virus in vitro and in vivo
Hongwei Xiang, Jixue Qiao, H Lin, et al.
Veterinary Microbiology (2024) Vol. 298, pp. 110244-110244
Closed Access | Times Cited: 2

The role of artificial intelligence in drug screening, drug design, and clinical trials
Yaojiong Wu, Li Ma, Xinyi Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2

Novel Computational Methods for Cancer Drug Design
Sekhar Talluri, Mohammad Amjad Kamal, Rama Rao Malla
Current Medicinal Chemistry (2023) Vol. 31, Iss. 5, pp. 554-572
Closed Access | Times Cited: 5

Advances in methods and concepts provide new insight into antibiotic fluxes across the bacterial membrane
Julia Vergalli, Matthieu Réfregiers, Paolo Ruggerone, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 1

Emerging trends in computational approaches for drug discovery in molecular biology
Yakubu Magaji Yuguda, Israel Ebehitale Unuebho, Tejonidhi kolli, et al.
GSC Biological and Pharmaceutical Sciences (2023) Vol. 24, Iss. 3, pp. 202-213
Open Access | Times Cited: 3

Advances and critical assessment of machine learning techniques for prediction of docking scores
Lukáš Bučinský, Marián Gall, Ján Matúška, et al.
International Journal of Quantum Chemistry (2023) Vol. 123, Iss. 24
Closed Access | Times Cited: 2

Protein engineering for natural product biosynthesis: expanding diversity for therapeutic applications
Sarah Otun, Jordy Alexis Lerma-Escalera, Khayalethu Ntushelo, et al.
Journal of Bio-X Research (2023) Vol. 06, Iss. 02, pp. 49-60
Open Access | Times Cited: 2

Structure‐Based Ultra‐Large Virtual Screenings
Christoph Gorgulla
(2024), pp. 441-470
Closed Access

Quantum AI in Healthcare : Revolutionizing Diagnosis, Treatment and Drug Discovery
Nisha Banerjee, Koyel Chatterjee
International Journal of Scientific Research in Science and Technology (2024) Vol. 11, Iss. 3, pp. 815-836
Open Access

Quantum‐Enabled Drug Discovery Process
Abhishek Rao, Deepika Kumari, Satyendra Singh, et al.
(2024), pp. 27-55
Closed Access

From roots to codes: Applications of computer-aided drug discovery from medicinal plants
Amina Javid, Areej Fatima, M Alkahtani Hamad, et al.
South African Journal of Botany (2024) Vol. 173, pp. 159-174
Closed Access

Page 1 - Next Page

Scroll to top